Biochemical disease-free survival in patients with a high prostate-specific antigen level (20–100 ng/mL) and clinically localized prostate cancer after radical prostatectomy.
Autor: | Brandli, D.W., Koch, M.O., Foster, R.S., Bihrle, R., Gardner, T.A. |
---|---|
Zdroj: | BJU International. Jul2003, Vol. 92 Issue 1, p19. 5p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |